Bridgeway Capital Management’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-69,000
| Closed | -$19.3K | – | 1339 |
|
|
2023
Q4 | $19.3K | Hold |
69,000
| – | – | ﹤0.01% | 1341 |
|
|
2023
Q3 | $24.8K | Hold |
69,000
| – | – | ﹤0.01% | 1338 |
|
|
2023
Q2 | $21.5K | Hold |
69,000
| – | – | ﹤0.01% | 1360 |
|
|
2023
Q1 | $23.4K | Hold |
69,000
| – | – | ﹤0.01% | 1350 |
|
|
2022
Q4 | $21.9K | Hold |
69,000
| – | – | ﹤0.01% | 1336 |
|
|
2022
Q3 | $30K | Sell |
69,000
-70,000
| -50% | -$30.4K | ﹤0.01% | 1373 |
|
|
2022
Q2 | $74K | Hold |
139,000
| – | – | ﹤0.01% | 1254 |
|
|
2022
Q1 | $132K | Hold |
139,000
| – | – | ﹤0.01% | 1235 |
|
|
2021
Q4 | $136K | Hold |
139,000
| – | – | ﹤0.01% | 1196 |
|
|
2021
Q3 | $206K | Sell |
139,000
-70,000
| -33% | -$104K | ﹤0.01% | 1200 |
|
|
2021
Q2 | $343K | Sell |
209,000
-39,700
| -16% | -$65.2K | 0.01% | 1178 |
|
|
2021
Q1 | $445K | Buy |
248,700
+56,500
| +29% | +$101K | 0.01% | 1119 |
|
|
2020
Q4 | $300K | Hold |
192,200
| – | – | 0.01% | 1118 |
|
|
2020
Q3 | $200K | Buy |
192,200
+65,000
| +51% | +$67.6K | ﹤0.01% | 1176 |
|
|
2020
Q2 | $76K | Buy |
+127,200
| New | +$76K | ﹤0.01% | 1259 |
|